Clinical Trial Update: Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating atropine eye drops (0.02% and 0.04%) combined with Defocus DIMS lenses for moderate to high myopia control; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: Ruihua Wei | Conditions: Myopia | Phase 1, Phase 2 | Status: RECRUITING